Literature DB >> 12022353

Change in final diagnosis on second evaluation of labial minor salivary gland biopsies.

Frederick B Vivino1, Indira Gala, George A Hermann.   

Abstract

OBJECTIVE: We evaluated the diagnostic accuracy of labial salivary gland specimens from a group of patients with symptoms or signs of dry mouth and/or dry eyes referred for assessment of possible Sjögren's syndrome (SS).
METHODS: Fifty-eight individuals (52 women, 6 men; median age 54.5 yrs, range 19-90) had previously undergone one (n = 58) or 2 (n = 2) labial salivary gland biopsies, serologic studies, and objective tests for dry eyes and/or dry mouth to diagnose possible SS. Patients were referred to our institution for a second opinion regarding diagnosis and/or management of SS. All biopsy specimens underwent blinded review to measure aggregate glandular area, identify lymphocytic foci, and calculate focus scores that might verify the submitted diagnoses. Results were classified according to accepted histologic criteria: chronic sialadenitis, focal lymphocytic sialadenitis, indeterminate, insufficient tissue for diagnosis, and within normal limits. Institutional sources of submitted diagnoses included university hospitals (n = 26), university affiliates (n = 9), community hospitals (n = 18), commercial laboratories (n = 6), and a governmental agency (n = 1).
RESULTS: Upon reexamination, 32 of 60 accessions (53%) sustained a revision of the initial diagnosis. Application of the focus scoring system combined with clinical features to reveal 12 hitherto undocumented cases of SS and refuted the diagnosis of SS in 8 instances. The principal reason for inaccurate initial interpretation was failure to apply the focus scoring system in 58 of 60 instances. Median diagnostic delay for the 12 SS cases was 302 days (range 55-2821).
CONCLUSION: It is possible that widespread cross-institutional failure to apply the focus scoring system in the interpretation of labial salivary gland biopsies may delay the recognition and/or treatment of SS.

Entities:  

Mesh:

Year:  2002        PMID: 12022353

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Sjögren's syndrome criteria.

Authors:  R Manthorpe
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 3.  The oral component of Sjögren's syndrome: pass the scalpel and check the water.

Authors:  Ava J Wu
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

4.  MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.

Authors:  Ilias Alevizos; Stefanie Alexander; R James Turner; Gabor G Illei
Journal:  Arthritis Rheum       Date:  2011-02

5.  Identification of potential genomic biomarkers for Sjögren's syndrome using data pooling of gene expression microarrays.

Authors:  Sadik A Khuder; Ibtisam Al-Hashimi; Anand B Mutgi; Nezam Altorok
Journal:  Rheumatol Int       Date:  2014-10-20       Impact factor: 2.631

6.  Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.

Authors:  Troy E Daniels; Darren Cox; Caroline H Shiboski; Morten Schiødt; Ava Wu; Hector Lanfranchi; Hisanori Umehara; Yan Zhao; Stephen Challacombe; Mi Y Lam; Yvonne De Souza; Julie Schiødt; Helena Holm; Patricia A M Bisio; Mariana S Gandolfo; Toshioki Sawaki; Mengtao Li; Wen Zhang; Beni Varghese-Jacob; Per Ibsen; Alicia Keszler; Nozomu Kurose; Takayuki Nojima; Edward Odell; Lindsey A Criswell; Richard Jordan; John S Greenspan
Journal:  Arthritis Rheum       Date:  2011-07

Review 7.  [Is bioptic assurance reasonable in patients with Sjögren's syndrome? From focus score to diagnosing vasculitides].

Authors:  V Krenn; M Jakobs; J Kriegsmann; M G Krukemeyer; A Rieger
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

8.  [Labial salivary gland biopsy in Sjögren's syndrome].

Authors:  A Dankof; L Morawietz; E Feist
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

9.  Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.

Authors:  Jelle L Vosters; Melissa A Landek-Salgado; Hongen Yin; William D Swaim; Hiroaki Kimura; Paul P Tak; Patrizio Caturegli; John A Chiorini
Journal:  Arthritis Rheum       Date:  2009-12

10.  Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Marta Perez-De-Lis; Iratxe Jimenez; Maria-Jose Blanco; Albert Bove; Maria-Jose Soto; Miriam Akasbi; Candido Diaz; Juan Sentís; Antoni Siso
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.